Skip to main
SIBN
SIBN logo

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 12 analyst ratings
Strong Buy
Strong Buy 58%
Buy 42%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc demonstrated strong financial performance in 4Q24, reporting total revenue of $49 million, which reflects a significant 26% year-over-year growth and aligns closely with previously announced figures. The company expanded its direct sales force, increasing the number of U.S. sales territories to 87, and saw a 23% year-over-year rise in active surgeons, reaching approximately 1,400, indicating a robust and expanding market presence. Furthermore, SI-BONE's gross margin improved to 79.1%, exceeding both consensus expectations and the company's own fiscal guidance, supported by higher sales rep productivity and increasing procedure volumes per physician.

Bears say

The analysis reveals a negative outlook for SI-BONE, primarily due to anticipated lower-than-expected revenue growth in the United States and ongoing weaknesses in international markets, compounded by pricing challenges. The company faces multiple risks, including increased competition, patent expirations, and potential reimbursement challenges, which could negatively affect sales and profitability. Additionally, SI-BONE has a history of significant losses, with expectations that this trend will continue, leading to a need for additional capital amidst operational challenges.

SI-BONE Inc (SIBN) has been analyzed by 12 analysts, with a consensus rating of Strong Buy. 58% of analysts recommend a Strong Buy, 42% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 12 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of Aug 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.